Cart
sales@molnova.com
DS16570511 B
CAS No. 2446154-84-1
DS16570511 B( —— )
Catalog No. M32895 CAS No. 2446154-84-1
DS16570511 is a novel, cell-permeable inhibitor targeting the mitochondrial calcium uniporter. It effectively blocks the increase in Ca2+ influx dependent on MCU or MICU1 .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 610 | In Stock |
|
| 10MG | 867 | In Stock |
|
| 25MG | 1302 | In Stock |
|
| 50MG | 1721 | In Stock |
|
| 100MG | 2325 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDS16570511 B
-
NoteResearch use only, not for human use.
-
Brief DescriptionDS16570511 is a novel, cell-permeable inhibitor targeting the mitochondrial calcium uniporter. It effectively blocks the increase in Ca2+ influx dependent on MCU or MICU1 .
-
DescriptionDS16570511 is a novel, cell-permeable inhibitor targeting the mitochondrial calcium uniporter. It effectively blocks the increase in Ca2+ influx dependent on MCU or MICU1 .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2446154-84-1
-
Formula Weight562.44
-
Molecular FormulaC30H25Cl2N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(C=1C=2C(N(CCCC(O)=O)C1)=CC=CC2)C3=CC(NCC=4C(=NOC4C)C5=C(Cl)C=CC=C5Cl)=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CRAC intermediate 1
CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors.
-
Iganidipine
Iganidipine（NKY 722） is a new water-soluble Ca2+ antagonist with antihypertensive activity for research and neurological related diseases.
-
Ca2+ channel agonist...
Ca2+ channel agonist 1 is an agonist of N-type Ca2+ channel and an inhibitor of Cdk2 (EC50s: 14.23 μM and 3.34 μM) and is used as a potential treatment for motor nerve terminal dysfunction.
